← Open Payments lookup

AMANDA KEFFER: Open Payments

NPI 1346864105 · GREENSBURG, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,309 in 60 payments from 10 companies in 2025. Trend: 2023 $2,915 · 2024 $3,311 · 2025 $1,309

Food & beverage: $1,309
CompanyPaymentsAmount
Axsome Therapeutics, Inc.11$418
Vanda Pharmaceuticals Inc.12$211
ABBVIE INC.20$183
Neurocrine BioSciences, Inc.2$154
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)4$88
Alkermes, Inc.4$85
Teva Pharmaceuticals USA, Inc.2$72
Janssen Pharmaceuticals, Inc2$48
Sage Therapeutics, LLC2$34
Takeda Pharmaceuticals U.S.A., Inc.1$16

Products named: Auvelity, VRAYLAR, INGREZZA, FANAPT, HETLIOZ, CAPLYTA, ARISTADA, UZEDY.

Industry payments across PA — which companies pay providers there.